Connection
Jennifer Dotson to Adolescent
This is a "connection" page, showing publications Jennifer Dotson has written about Adolescent.
|
|
Connection Strength |
|
 |
|
 |
|
1.272 |
|
|
|
-
Farmer PF, Chen HF, Cooper J, Boyle B, Maltz RM, Michel HK, Dotson JL. Healthcare resource utilization and cost trends in pediatric inflammatory bowel disease within an accountable care organization. J Pediatr Gastroenterol Nutr. 2025 Oct; 81(4):1034-1044.
Score: 0.107
-
Smith J, Jacobson-Kelly A, Donegan A, Boyle B, Maltz RM, Michel HK, Dotson JL. Diagnosis and Treatment of Iron Deficiency and Anemia in Youth With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2023 03 01; 76(3):313-318.
Score: 0.089
-
Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis. 2022 09 01; 28(9):1420-1429.
Score: 0.087
-
Pearlstein H, Bricker J, Michel HK, Afzali A, Donegan AM, Maltz RM, Boyle BM, Dotson JL. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 04 01; 72(4):563-568.
Score: 0.079
-
Gupta SR, Crandall WV, Donegan A, Johnson M, Drobnic B, Oates M, Boyle B, Maltz RM, Dotson JL. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2019 11; 69(5):544-550.
Score: 0.072
-
Dotson JL, Kappelman MD, Bricker J, Andridge R, Chisolm DJ, Crandall WV. Multicenter Evaluation of Emergency Department Treatment for Children and Adolescents With Crohn's Disease According to Race/Ethnicity and Insurance Payor Status. Inflamm Bowel Dis. 2019 01 01; 25(1):194-203.
Score: 0.068
-
Jain A, Bricker J, Kappelman MD, Dotson JL. Obesity Does Not Affect Early Outcomes in Children With Newly Diagnosed Crohn Disease. J Pediatr Gastroenterol Nutr. 2018 Nov; 67(5):622-625.
Score: 0.067
-
Dotson JL, Cho M, Bricker J, Kappelman MD, Chisolm DJ, Tomer G, Crandall WV. Race Differences in Initial Presentation, Early Treatment, and 1-year Outcomes of Pediatric Crohn's Disease: Results from the ImproveCareNow Network. Inflamm Bowel Dis. 2017 05; 23(5):767-774.
Score: 0.060
-
Dotson JL, Bricker JB, Kappelman MD, Chisolm D, Crandall WV. Assessment of Sex Differences for Treatment, Procedures, Complications, and Associated Conditions Among Adolescents Hospitalized with Crohn's Disease. Inflamm Bowel Dis. 2015 Nov; 21(11):2619-24.
Score: 0.054
-
Dotson JL, Bashaw H, Nwomeh B, Crandall WV. Management of intra-abdominal abscesses in children with Crohn's disease: a 12-year, retrospective single-center review. Inflamm Bowel Dis. 2015 May; 21(5):1109-14.
Score: 0.052
-
Dotson JL, Kappelman MD, Chisolm DJ, Crandall WV. Racial disparities in readmission, complications, and procedures in children with Crohn's disease. Inflamm Bowel Dis. 2015 Apr; 21(4):801-8.
Score: 0.052
-
Dotson JL, Crandall WV, Zhang P, Forrest CB, Bailey LC, Colletti RB, Kappelman MD. Feasibility and validity of the pediatric ulcerative colitis activity index in routine clinical practice. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2):200-4.
Score: 0.052
-
Dotson JL, Crandall W, Mousa H, Honegger JR, Denson L, Samson C, Cunningham D, Balint J, Dienhart M, Jaggi P, Carvalho R. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis. 2011 Jan; 17(1):56-61.
Score: 0.039
-
Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo D, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Langton CR, Crandall W. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr. 2010 Aug; 51(2):140-5.
Score: 0.038
-
Davidson N, Morris GA, Wright MA, Brock G, Boyle B, Dotson JL, Michel HK, Maltz RM. Predictors of antitumor necrosis factor primary nonresponse and drug durability in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2025 Oct; 81(4):1024-1033.
Score: 0.027
-
Ta AD, Dillman JR, Ollberding NJ, Haberman Y, Baldassano R, Markowitz J, Otley A, Dotson JL, Pfefferkorn M, Hyams JS, Heyman MB, Kim SC, Noe J, Snapper S, Alazraki A, Kugathasan S, Denson LA. Baseline terminal ileal CT and MRI measurements are associated with imaging outcomes in pediatric Crohn's disease: a cohort study. Pediatr Radiol. 2025 Jul; 55(8):1642-1651.
Score: 0.027
-
Zhang D, Stein R, Lu Y, Zhou T, Lei Y, Li L, Chen J, Arnold J, Becich MJ, Chrischilles EA, Chuang CH, Christakis DA, Fort D, Geary CR, Hornig M, Kaushal R, Liebovitz DM, Mosa ASM, Morizono H, Mirhaji P, Dotson JL, Pulgarin C, Sills MR, Suresh S, Williams DA, Baldassano RN, Forrest CB, Chen Y. Pediatric Gastrointestinal Tract Outcomes During the Postacute Phase of COVID-19. JAMA Netw Open. 2025 02 03; 8(2):e2458366.
Score: 0.026
-
Wright JC, Ardura MI, Dotson JL, Boyle B, Maltz RM, Michel HK. Management and outcomes of histoplasmosis in youth with inflammatory bowel disease in an endemic area. J Pediatr Gastroenterol Nutr. 2024 Dec; 79(6):1153-1163.
Score: 0.025
-
McLaughlin JF, Linville T, Jester TW, Marciano TA, Lazare F, Dotson JL, Samson C, Niklinska-Schirtz B, Cabrera J, Leibowtiz I, Batra S, Ammoury R, Strople JA, Saeed S, Sandberg KC, Tung J, Verstraete SG, Cox RF, Na S, Steiner SJ, Ali SA, Israel EJ, Dorsey J, Adler J, Rekhtman Y, Egberg MD, Waduge ER, Savas J, Brensinger CM, Lewis JD, Kappelman MD. Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2025 Apr; 23(5):825-834.
Score: 0.025
-
Iovino NA, McClinchie MG, Abdel-Rasoul M, Boyle B, Dotson JL, Michel HK, Maltz RM. Clinical impacts of immunomodulator withdrawal from anti-tumor necrosis factor combination therapy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 Oct; 79(4):885-894.
Score: 0.025
-
Moore MM, Gee MS, Iyer RS, Chan SS, Ayers TD, Bardo DME, Chandra T, Cooper ML, Dotson JL, Gadepalli SK, Gill AE, Levin TL, Nadel HR, Schooler GR, Shet NS, Squires JH, Trout AT, Wall JJ, Rigsby CK. ACR Appropriateness Criteria? Crohn Disease-Child. J Am Coll Radiol. 2022 05; 19(5S):S19-S36.
Score: 0.021
-
Jain A, Bricker J, Kappelman MD, Dotson JL. Overweight and Obese Status Is Not Associated With Disease Activity for Children and Adolescents With Newly Diagnosed Inflammatory Bowel Disease. Am J Gastroenterol. 2022 07 01; 117(7):1146-1153.
Score: 0.021
-
Yossef L, Wright M, Benedict J, Morris GA, McNicol M, Boyle B, Dotson JL, Michel HK, Maltz RM. Patient and Caregivers' Perspectives on Biosimilar Use in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2022 07 01; 75(1):59-63.
Score: 0.021
-
Gray A, Boyle B, Michel HK, Wright M, Dotson JL, Maltz RM. Risk of Post-Resection Recurrence in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr. 2022 06 01; 74(6):794-800.
Score: 0.021
-
Jacobson-Kelly AE, Stanek JR, Powers JM, Dotson JL, O'Brien SH. Trends in Anemia, Iron, Therapy, and Transfusion in Hospitalized Pediatric Patients with Inflammatory Bowel Disease. J Pediatr. 2020 07; 222:141-145.e1.
Score: 0.019
-
Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 09; 67(3):341-345.
Score: 0.017
-
Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr. 2018 Jun; 66(6):909-914.
Score: 0.016
-
Huntington JT, Boomer LA, Pepper VK, Diefenbach KA, Dotson JL, Nwomeh BC. Single-incision laparoscopic surgery (SILS) for children with Crohn's disease. Pediatr Surg Int. 2016 May; 32(5):459-64.
Score: 0.014
-
Huntington JT, Boomer LA, Pepper VK, Diefenbach KA, Dotson JL, Nwomeh BC. Minimally Invasive Ileal Pouch-Anal Anastomosis with Rectal Eversion Allows for Equivalent Outcomes in Continence in Pediatric Patients. J Laparoendosc Adv Surg Tech A. 2016 Mar; 26(3):222-5.
Score: 0.014
-
Pusateri AJ, Kim SC, Dotson JL, Balint JP, Potter CJ, Boyle BM, Crandall WV. Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2015 May; 60(5):592-7.
Score: 0.013
-
Vergidis P, Avery RK, Wheat LJ, Dotson JL, Assi MA, Antoun SA, Hamoud KA, Burdette SD, Freifeld AG, McKinsey DS, Money ME, Myint T, Andes DR, Hoey CA, Kaul DA, Dickter JK, Liebers DE, Miller RA, Muth WE, Prakash V, Steiner FT, Walker RC, Hage CA. Histoplasmosis complicating tumor necrosis factor-a blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015 Aug 01; 61(3):409-17.
Score: 0.013
-
Lee GJ, Dotson JL, Kappelman MD, King E, Pratt JM, Colletti RB, Bistrick S, Burkam JL, Crandall WV. Seasonality and pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014 Jul; 59(1):25-8.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|